16 July 2024
DLA Piper advises Jones in Elicio Therapeutics’ US$40 million ATM and US$11.5 million public offering
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Josh Kaufman Lead | DLA Piper | Partner | Capital Markets and Public Companies Advisory | New York |
| Stephen Alicanti | DLA Piper | Partner | Capital Markets | New York |
| Christopher Mikson | DLA Piper | Partner | Not stated | Washington DC |
| Kim McKenzie | DLA Piper | Associate | Not stated | Raleigh |
| Sarah Cooper | DLA Piper | Associate | Not stated | Seattle |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 40m (US$40 million)
- What the figure measures
- Issue size
- Client
- JonesTrading Institutional ServicesUnderwriters
- Counterparties
- Elicio Therapeutics (Issuer)